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Tissue-type plasminogen activator (tPA) is a serine proteinase released by the
presynaptic terminal of cerebral cortical neurons following membrane depolarization
(Echeverry et al., 2010). Recent studies indicate that the release of tPA triggers the
synaptic vesicle cycle and promotes the exocytosis (Wu et al., 2015) and endocytic
retrieval (Yepes et al., 2016) of glutamate-containing synaptic vesicles. Here we
used electron microscopy, proteomics, quantitative phosphoproteomics, biochemical
analyses with extracts of the postsynaptic density (PSD), and an animal model
of cerebral ischemia with mice overexpressing neuronal tPA to study whether the
presynaptic release of tPA also has an effect on the postsynaptic terminal. We found
that tPA has a bidirectional effect on the composition of the PSD of cerebral cortical
neurons that is independent of the generation of plasmin and the presynaptic release of
glutamate, but depends on the baseline level of neuronal activity and the extracellular
concentrations of calcium (Ca2+). Accordingly, in neurons that are either inactive or
incubated with low Ca2+ concentrations tPA induces phosphorylation and accumulation
in the PSD of the Ca2+/calmodulin-dependent protein kinase IIα (pCaMKIIα), followed
by pCaMKIIα-mediated phosphorylation and synaptic recruitment of GluR1-containing
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. In contrast,
in neurons with previously increased baseline levels of pCaMKIIα in the PSD due to
neuronal depolarization in vivo or incubation with high concentrations of either Ca2+
or glutamate in vitro, tPA induces pCaMKIIα and pGluR1 dephosphorylation and their
subsequent removal from the PSD. We found that these effects of tPA are mediated
by synaptic N-methyl-D-aspartate (NMDA) receptors and cyclin-dependent kinase 5
(Cdk5)-induced phosphorylation of the protein phosphatase 1 (PP1) at T320. Our
data indicate that by regulating the pCaMKIIα/PP1 balance in the PSD tPA acts as a
homeostatic regulator of the postsynaptic response of cerebral cortical neurons to the
presynaptic release of glutamate.
Keywords: tissue-type plasminogen activator (tPA), plasminogen, Ca2+/calmodulin-dependent protein kinase II
(CaMKII), homeostatic plasticity, protein phosphatase 1
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INTRODUCTION
Tissue-type plasminogen activator (tPA) is a serine proteinase
with pleotropic roles in the central nervous system (CNS).
Accordingly, tPA released from endothelial cells into the
intravascular space has a fibrinolytic effect mediated by its
ability to catalyze the conversion of plasminogen into plasmin
(Camiolo et al., 1971), and tPA released from glia modulates
the permeability of the blood-brain barrier (BBB; Yepes et al.,
2003), induces neuroglial coupling (An et al., 2014) and
activates proinflammatory cell signaling pathways (Zhang et al.,
2007). Intriguingly, the rapid release of neuronal tPA following
membrane depolarization also has a robust effect on synaptic
function. In line with these observations, a growing body
of experimental evidence indicates that tPA mediates the
development of neuronal plasticity in in vitro and in vivo
models of long-term potentiation (Qian et al., 1993), visual
cortex plasticity (Müller and Griesinger, 1998), learning (Seeds
et al., 1995, 2003) and stress-induced anxiety (Pawlak et al.,
2003).
Recent studies indicate that one of the mechanisms whereby
tPA induces synaptic plasticity is by regulating the composition
of the active zone and promoting the exocytosis (Wu et al.,
2015) and subsequent endocytic retrieval (Yepes et al., 2016)
of glutamate-containing synaptic vesicles from the presynaptic
terminal of cerebral cortical neurons. However, although these
effects are pivotal for the development of synaptic plasticity,
the sustained activation of the synaptic vesicle cycle may also
cause an excitotoxic injury to the postsynaptic terminal, which
would suggest a neurotoxic effect for tPA in the CNS (Wang
et al., 1998). Yet, these observations are in sharp contrast
with a growing body of experimental evidence indicating that
tPA has a neuroprotective effect in the brain mediated by its
ability to activate cell signaling pathways that are pivotal for
the detection and adaptation to metabolic stress (Echeverry
et al., 2010; Haile et al., 2012; Wu et al., 2012, 2013a; Yepes,
2015).
The postsynaptic density (PSD) is a highly dynamic
electron-dense structure anchored to the inner surface of the
postsynaptic terminal that contains protein complexes that
regulate the postsynaptic response to the presynaptic release
of neurotransmitters. The composition and size of the PSD
change rapidly in response to variations in synaptic activity. For
example, cerebral ischemia, glutamate treatment, and membrane
depolarization (Aronowski and Grotta, 1996; Martone et al.,
1999; Dosemeci et al., 2001) cause a rapid increase in its thickness
associated with phosphorylation and accumulation of the alpha
subunit of the Ca2+/calmodulin-dependent protein kinase II
(CaMKIIα).
CaMKIIα is a serine/threonine kinase that regulates the
postsynaptic response of excitatory glutamatergic synapses to
increase in the concentration of Ca2+ (Shakiryanova et al.,
2011). Under resting conditions, substrate access to the CaMKIIα
binding site is blocked by the autoinhibitory pseudosubstrate
segment of the protein. However, the influx of Ca2+ leads
to Ca2+/calmodulin-dependent phosphorylation of CaMKIIα at
T286 (pCaMKIIα), relieving its autoinhibition and rendering
the kinase active even after Ca2+ is removed (Hell, 2014).
CaMKIIα phosphorylation has a direct effect on synaptic
activity under physiological and pathological conditions (Lisman
et al., 2012; Skelding et al., 2012). For example, glutamatergic
synapses that are ‘‘silent’’ because they harbor N-methyl-
D-aspartate (NMDA) but not α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA) receptors, become active
following pCaMKIIα-induced phosphorylation and recruitment
of GluR1-containing AMPA receptors to the PSD (Liao et al.,
2001).
Several serine/threonine protein phosphatases (PP) can
dephosphorylate and thus regulate pCaMKIIα activity.
However, although protein phosphatase 1 (PP1), PP2A
and PP2C can all dephosphorylate pCaMKIIα (Strack
et al., 1997), each PP seems to act in a specific cellular
compartment. Hence, while pCaMKIIα is targeted selectively
in the cytosol by PP2A, in the PSD pCaMKIIα is primarily
dephosphorylated by PP1 (Shields et al., 1985). PP1 activity
is regulated by its interaction with a group of inhibitory
proteins that includes the inhibitor-1 (I-1; Endo et al.,
1996), the I-1 homolog DARPP-32, and inhibitor-2 (I-2;
Huang et al., 1999). Protein kinase A (PKA)-dependent
I-1 phosphorylation at T35 stabilizes the PP1-I-1 complex,
thereby suppressing PP1 activity. Conversely, PP1 is
activated by calcineurin-mediated I-1 dephosphorylation
at T35 (Colbran, 2004). Despite the relevance of these
observations, recent experimental evidence has uncovered
calcineurin- and I-1-independent mechanisms for the
regulation of neuronal PP1 activity. For example, cyclin-
dependent kinase 5 (Cdk5)-induced PP1 phosphorylation
at T320 inhibits PP1 by blocking access to its substrates
(Goldberg et al., 1995); importantly, several studies indicate
that this mechanism of PP1 regulation is pivotal for the
control of the G2/M phase of the cell cycle (Kwon et al.,
1997) and the development of synaptic plasticity (Hou et al.,
2013).
The work presented here indicates that the presynaptic
release of tPA has a bidirectional effect on the composition and
function of the postsynaptic terminal of glutamatergic synapses
of cerebral cortical neurons that depends on the baseline levels
of neuronal activity and the extracellular concentrations of
Ca2+. Hence, in neurons with low baseline levels of CaMKIIα
tPA induces its NMDAR-mediated phosphorylation at T286
(pCaMKIIα) and subsequent accumulation in the PSD. These
events are followed by pCaMKIIα-induced phosphorylation
and recruitment of GluR1-containing AMPARs to the PSD. In
contrast, in neurons with high baseline levels of pCaMKIIα
and pGluR1-containing AMPARs in the PSD due to neuronal
depolarization in vivo or incubation with high concentrations of
Ca2+ or glutamate in vitro, tPA induces their dephosphorylation
and subsequent removal to extrasynaptic sites. We found that
this homeostatic effect is mediated by tPA’s ability to regulate
the Cdk5-dependent phosphorylation of PP1 at T320. Based on
these data, here we propose a model in which the presynaptic
release of tPA is a homeostatic mechanism that modulates the
response of the postsynaptic terminal to the presynaptic release
of glutamate.
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MATERIALS AND METHODS
Animals and Reagents
Strains were 8–12 weeks-old male wild-type (Wt) and T4 mice
(with a 20-fold increase in tPA expression in neurons (Madani
et al., 1999), kindly provided by Professor J. D. Vassalli
and Dr. R. Mandani, University of Geneva, Switzerland) on
a C57BL/6J background. Experiments were approved by the
Institutional Animal Care and Use Committee of Emory
University, Atlanta GA, following guidelines established by
ARRIVE (Animal Research: reporting in vivo Experiments).
Recombinant murine tPA and proteolytically inactive tPA
(itPA) with an alanine for serine substitution at the active
site Ser481 (S481A) were acquired from Molecular Innovations
(Novi, MI, USA). Other reagents were antibodies against the
following proteins: protein phosphatase (I-1) phosphorylated
at T35 (Santa Cruz Biotechnologies; Santa Cruz, CA, USA),
PP1 phosphorylated at T320 (Cell Signaling; Boston, MA,
USA), microtubule-associated protein- 2 and β-actin (MAP-2;
Sigma-Aldrich; St. Louis, MO, USA), postsynaptic density
protein-95 (PSD-95), and CaMKIIα phosphorylated at T286,
total GluR1 and GluR1 phosphorylated at S831 (Abcam,
Cambridge, MA, USA). The cell permeable calcium chelator
BAPTA-AM, bicuculline, the NMDA receptor blocker MK-801,
tetrodotoxin (TTX), and the cell-permeable CaMKII inhibitor
KN-62 were purchased from Tocris Bioscience (Minneapolis,
MN, USA). Other reagents were glycine, glutamate, and the
proteosomal inhibitor MG132 (Sigma-Aldrich, St. Louis, MO,
USA), protease and phosphatase inhibitors (Roche, Indianapolis,
IN, USA), DABCO mounting media (Fluka, St. Louis, MO,
USA) and the Cdk-5 inhibitor roscovitine (Rosc; Calbiochem;
Billerica, MA, USA).
Neuronal Cultures
Cerebral cortical neurons were cultured from E16 to E18 Wt
mice as described elsewhere (Wu et al., 2012). Briefly, the
cerebral cortex was dissected, transferred into Hanks’ balanced
salt solution containing 100 units/ml penicillin, 100 µg/ml
streptomycin, and 10 mM HEPES, and incubated in trypsin
containing 0.02% DNase at 37◦C for 15 min. Then tissue
was triturated, and the supernatant was re-suspended in
B27-supplemented neurobasal medium containing 2 mM
l-glutamine and plated onto 0.1mg/ml poly-l-lysine-coated wells.
Isolation of Synaptoneurosomes and
PSD-Enriched Fractions
Wt cerebral cortical neurons were treated as described below.
The forebrain of T4 mice and their Wt littermate controls
was extracted after bilateral common carotid artery occlusion
(BCCAO) as described below, scrapped in cold fractionation
buffer (1 mM EGTA, 0.25 M sucrose, 25 mM HEPES pH 8.1)
in the presence of inhibitors of proteases and phosphatases.
Cells and tissue were homogenized using a 5 ml tissue grinder,
and the homogenate was centrifuged at 2000 g for 5 min to
remove cell debris. The supernatant (S1) was transferred to a
new tube and centrifuged at 32,000 g for 10 min. The pellet
(P2) containing synaptoneurosomes and used or resuspended
in 1 ml of a solution containing 150 mM KCl and 0.5%
Triton and centrifuged at 275,000 g for 1 h to extract the
PSD. The pellets (P3) were washed again with 0.5 ml of
150 mM KCl and 0.5% Triton buffer, and centrifuged at
275,000 g for 1 h. The PSD-containing pellets (P3) were lysed
in 50 mM Tris-HCl/0.3% SDS buffer for protein assay. To
test the purity of these preparations, extracts were probed with
Western blot analysis with antibodies against PSD-95 (detects
the PSD), syntaxin-1 (detects the presynaptic membrane) and
synaptophysin (detects synaptic vesicles). Our data indicate
that these extracts are highly enriched for PSD-95 and have
undetectable levels of both syntaxin-1 and synaptophysin (data
not shown).
Bilateral Common Carotid Artery
Occlusion (BCCAO)
Wt and T4 mice were anesthetized with isofluorane and their
carotid arteries were exposed and either clipped during 1 min or
kept patent (sham operation), as described elsewhere (Echeverry
et al., 2010). A second group of animals underwent 5 min of
reperfusion followed by either a second episode of 60 s BCCAO
or sham-operation. Cerebral perfusion in the forebrain was
monitored with a laser Doppler (Perimed), and only animals with
>85% decrease in cerebral perfusion with complete reperfusion
after BCCAO were included in this study. Immediately after
the end of BCCAO, animals were transcardially perfused with
cold PBS, brains were harvested and their cerebral cortex was
dissected.
Western Blot Analysis
Wt cerebral cortical neurons (n = 4 per group) were incubated
with either vehicle (control) or 5 nM of tPA during 1.5, 3 or
5 min; or with 5 nM of proteolytically active or inactive tPA
during 5 min in the presence of either 10 µM of MK-801,
or 20 µM of BAPTA-AM, or 10 µM of the cell-permeable
CaMKII inhibitor KN-62; or with either BAPTA-AM or KN-62
alone; or during 5 min with 200 µM of glycine and 20 µM
of bicuculline and 2 µM or 10 µM of glutamate, in the
presence of either vehicle (control) or 5 nM of tPA, or
pretreated during 30 min or 4 h with either 1 µM of TTX,
or 50 µM of Rosc or 10 µM of the proteosome inhibitor
MG132, respectively, followed by treatment with 5 nM of tPA.
The forebrain of Wt and T4 mice (n = 4 animals per group)
was harvested immediately after either 1-min of BCCAO or
sham-operation, or 1 min of BCCAO followed by 5 min of
reperfusion and another minute of either BCCAO or sham-
operation. In each case PSD-enriched fractions prepared as
described above were homogenized, protein concentration was
quantified using the BCA assay, and 2.5 µg were loaded per
sample, separated by 4–20% linear gradient polyacrylamide
gel, transferred to a PVDF membrane by semi-dry transfer
system, blocked with 5% non-fat dry milk in Tris-buffered
saline pH 8.0 with 0.1% Tween 20 buffer, and immunoblotted
with antibodies against pCaMKIIα (1:1000), total CamKII,
(1:5000), PSD-95 (1:1000), β-actin (1:5000), pGluR1 (1:1000),
total GluR1 (1:1000), I-1 phosphorylated at T35 (1:1000) or
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PP1 phosphorylated at T320 (1:1000). Each observation was
repeated 4–14 times.
Proteomics and Quantitative
Phosphoproteomics
Proteomics and quantitative phosphoproteomics analyses were
performed as described elsewhere (Wu et al., 2012; Dammer
et al., 2015) in PSD extracts prepared from Wt cerebral cortical
neurons treated 60 s with 5 nM of tPA or vehicle (control;
n = 3 preparations per group). For pathway analysis we used
the DAVID Bioinformatics Database. Log2 (tPA-treated/control)
values of the average protein intensity ratios were centered
so that the fit gauss curve midpoint (mean) fell at zero.
Log2 values 1.96 standard deviations from the mean (changed
with 95% confidence, with absolute value greater than 0.709)
were considered as changing and these protein identities and
quantifications were considered in the analysis that followed.
Immunogold Electron Microscopy Studies
Brains from Wt and T4 mice (n = 4) were fixed by transcardial
perfusion with 4% PFA in 0.1 M phosphate buffer (pH 7.2)
for 20 min followed by immersion-fixation overnight at 4◦C.
Monolayers of Wt cerebral cortical neurons (n = 3 preparations)
were fixed with 4% PFA in 0.1 M PBS overnight at 4◦C. Brains
were harvested, sectioned onto 50 µm cuts and permeabilized in
0.05% Triton X-100 for 10 min. Cells were permeabilized with
0.1 µg/ml digitonin. After permeabilization, brain sections
and cells were incubated in PBS containing 5% rabbit serum,
5% BSA, and 0.1% gelatin to block potential non-specific
interaction between immunoreagents and samples. After several
washes brain sections and monolayer cells were fixed with 2.5%
glutaraldehyde in 0.1 M PB. Silver enhancement using Aurion
R-gen SE-EM kit was then conducted following manufacturer’s
instructions. Brain sections and monolayer cells were then
fixed with 0.5% osmium tetroxide for 15 min, dehydrated and
embedded in Eponate 12 resin. Then areas of the frontal cortex or
cell monolayers were dissected out from flat embedded vibrating
microtome sections and re-embedded, cut onto 70 nm sections,
stained with uranyl acetate and lead citrate, and examined with
a JEOL JEM-1400 transmission electron microscope (Tokyo,
Japan) equipped with a Gatan US100 CCD camera (Pleasenton,
CA, USA). The thickness of the PSD was measured as described
elsewhere (Dosemeci et al., 2001). Briefly, images were magnified
4× in ImageJ and the PSD was outlined by hand. The average
thickness of the PSD was calculated by dividing the area of
the outlined PSD by the length of the postsynaptic membrane.
Each observation was repeated in three different cultures and
120 observations were performed per culture, and in 4 Wt and
T4 mice (50 neurons were examined per animal at Bregma:
0.5 mm, lateral: 1 mm and ventral: 1 mm (Paxinos and Franklin,
2001) in each mouse.
Immunohistochemistry and Quantification
of pCaMKIIα , pGluR1 and Total GluR1
Wt cerebral cortical neurons were incubated during 90 s
in HBSS-containing 2.5 mM of calcium alone or in the
presence of 5 nM of proteolytically active or inactive tPA. A
second group of cells was incubated during 90 s with 5 nM
of active or proteolytically inactive tPA in the presence of
HBSS containing 0–1.8 mM of calcium. A third group of
cells were incubated during 90 s or 5 min in the presence
of 5 nM of tPA or vehicle (control) with HBSS media
containing 2.5 mM of calcium, 200 µM of glycine, 20 µM
of bicuculline and 1 µM of glutamate. The brains of Wt
and T4 mice (n = 4 per group) were harvested immediately
after 60 s of BCCAO or sham-operation, fixed and cut onto
20 µM sections at Bregma: 0.5 mm, lateral: 1 mm and
ventral: 1 mm (Paxinos and Franklin, 2001) cells were fixed
for 15 min in 4% paraformaldehyde containing 4% sucrose,
permeabilized for 5 min with 50 ug/ml digitonin prepared in
Tris buffer saline (TBS), blocked for 30 min in 0.1% casein,
5% goat or donkey serum and double labeled with antibodies
against CaMKIIα phosphorylated at T286 (1:2500) and MAP-2
(1:20,000), or antibodies against GluR1 phosphorylated at
S831 and PSD-95, and counterstained with phalloydin. A
sub-group group of cells was not permeabilized and stained with
antibodies against total GluR1. Brain cuts were stained with
antibodies against pCaMKIIα (1:10,000) and heat maps were
generated in photoshop. Coverslips were washed and mounted
using Polyvinyl-alcohol/DABCO mounting media. To quantify
pCaMKIIα, pGluR1 and GluR1-positive puncta, 60× pictures
taken from dendrites in each experimental group were
electronicallymagnified 4× and the number of either pCaMKIIα,
or pGluR1, or GluR1-positive puncta was quantified with the cell
counter of ImageJ.
Statistical Analysis
Statistical analysis was performed with two-tailed t test and
two-way analysis of variance (ANOVA) with Greenhouse-
Geisser correction, as appropriate. p-values of <0.05 were
consider as significant.
RESULTS
TPA Increases the Thickness of the
Postsynaptic Density of Cerebral Cortical
Neurons
Our earlier work indicates that tPA activates the synaptic vesicle
cycle in glutamatergic cerebral cortical neurons (Wu et al.,
2015). To investigate whether tPA also has an effect on the
postsynaptic terminal, we used electron microscopy to measure
the thickness of the PSD of Wt cerebral cortical neurons
incubated during 60 s with either 5 nM of tPA or a comparable
volume of vehicle (control). We chose this dose because our
previous studies indicate that it increases the concentration of
tPA in the synaptic cleft to values near to those most likely
found after the induction of membrane depolarization (Haile
et al., 2012). We found that the thickness of the PSD increases
from 24.44 ± 2.31 nm in vehicle (control)-treated neurons to
54.21± 2.71 nm in cells incubated with tPA (n = 360; p< 0.0001;
Figure 1).
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FIGURE 1 | Type plasminogen activator (tPA) increases the thickness of the postsynaptic density (PSD). (A) Representative electron microscopy
micrographs from the PSD of wild-type (Wt) cerebral cortical neurons incubated during 60 s with either vehicle (control; a,c) or 5 nM of tPA (b,d). Magnification
15,000× in (a,b) and 30,000× in (c,d). (B) Mean thickness of the PSD of 360 Wt cerebral cortical neurons per group incubated during 60 s with either vehicle
(control; white bar) or 5 nM of tPA (black bar). Lines denote SEM.
TPA Induces CaMKIIα Phosphorylation
Because protein recruitment to the PSD leads to an increase in
its thickness (Dosemeci et al., 2001), then we decided to use
liquid chromatography coupled to tandem mass spectrometry
(LC-MS/MS) to study changes in protein abundance in
synaptoneurosomes prepared from Wt cerebral cortical neurons
treated during 60 s with 5 nM of tPA or a comparable volume
of vehicle (control). Remarkably, these studies showed that
compared to vehicle (control)-treated neurons tPA induces a
160% increase in the abundance of CaMKIIα in the synapse
(p < 0.009). Because CaMKIIα translocates from the cytosol to
the PSD following its phosphorylation at T286 (pCaMKIIα), and
since the recruitment of pCaMKIIα has been associated with
increase in the thickness of the PSD during synaptic activity
(Dosemeci et al., 2001; Hell, 2014), then we decided to use
immobilized metal affinity chromatography (IMAC) followed
by LC-MS/MS to quantify the abundance of phosphorylated
proteins in synaptoneurosomes prepared from Wt cerebral
cortical neurons treated during 60 s with 5 nM of tPA
or a comparable volume of vehicle (control). We found
that compared to controls, synaptoneurosomes from neurons
treated with tPA have a 194% increase in the abundance of
pCaMKIIα.
Our data indicate that tPA increases the abundance of
pCaMKIIα in the synapse. Then, to determine whether this
effect occurs in the postsynaptic terminal, we quantified the
number of pCaMKIIα-positive puncta in 275 dendrites from
Wt cerebral cortical neurons treated during 60 s with 5 nM
of either proteolytically active or inactive tPA, or with a
comparable volume of vehicle (control). Our data indicate that
tPA increases the expression of pCaMKIIα in dendrites of Wt
cerebral cortical neurons, and that this effect does not require
the conversion of plasminogen into plasmin (Figures 2A,B).
Despite the fact that these experiments show that tPA increases
the expression of pCaMKIIα in the postsynaptic terminal, they
do not indicate that this necessarily happens in the PSD. Thus,
we decided to study the expression of pCaMKIIα in PSD
extracts prepared from Wt cerebral cortical neurons treated
with 5 nM of proteolytically active or inactive tPA. We found
that tPA increases the expression of pCaMKIIα in the PSD by
a mechanism that does not require the generation of plasmin
(Figures 2C,D), that this effect is maximal after 5 min of
incubation (Figures 2E,F) and that it requires the influx of
Ca2+ via NMDA receptors (Figures 2G,H). Importantly, our
loading controls with PSD-95 indicate that in each experimental
condition we probed equal concentrations of the PSD and that
therefore the observed effect of tPA on pCaMKIIα expression is
not an epiphenomenon caused by the increase in the thickness of
the PSD.
Our earlier work indicates that tPA induces the presynaptic
release of glutamate (Wu et al., 2015). Then it is conceivable
to postulate that the increase in pCaMKIIα abundance
observed in the PSD following treatment with tPA is caused
by glutamate released from the presynaptic terminal in
response to tPA treatment instead of a direct effect of tPA
on the postsynaptic terminal. To test this possibility we
studied the expression of pCaMKIIα in PSD extracts prepared
from Wt cerebral cortical neurons in which glutamatergic
neurotransmission was abrogated by incubation with TTX
before treatment with tPA. Our data indicate that the effect
of tPA on pCaMKIIα expression in the PSD is independent
of the effect of tPA on the presynaptic release of glutamate
(Figures 2I,J).
In previous studies we showed that 1 min of BCCAO
induces the rapid release of neuronal tPA without causing
cell death (Echeverry et al., 2010). Then, to study the in vivo
significance of our in vitro findings we quantified the thickness
of the PSD and the expression of pCaMKIIα in the cerebral
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FIGURE 2 | TPA induces Ca2+/calmodulin-dependent protein kinase II (CaMKIIα) phosphorylation and accumulation in the PSD. (A) Representative
immunocytochemical staining for microtubule-associated protein-2 (MAP-2; red) and CaMKIIα phosphorylated at T286 (pCaMKIIα; green and white) in dendrites
from Wt cerebral cortical neurons incubated 90 s with vehicle (control) or 5 nM of proteolytically active or inactive tPA (atPA and itPA, respectively). Magnification
100×. (B) Mean number of pCaMKIIα-positive puncta in 275 dendrites from Wt cerebral cortical neurons incubated 90 s with either vehicle (control; white bar), or
(Continued)
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FIGURE 2 | (Continued)
atPA (black bar), or itPA (gray bar). Lines denote SEM. (C,D) Experimental
design and representative Western blot analysis (C) and quantification of the
mean intensity of the band (D) for pCaMKIIα expression in extracts prepared
from the PSD of Wt cerebral cortical neurons incubated 90 s with vehicle
control, or 5 nM of either atPA or itPA. Lines denote SD; n = 4.
(E,F) Experimental design and representative Western blot analysis (E) and
quantification of the mean intensity of the band (F) for pCaMKIIα expression in
extracts from the PSD of Wt cerebral cortical neurons incubated 0–5 min with
5 nM of tPA. (G,H) Experimental design and representative Western blot
analysis (G) and quantification of the mean intensity of the band (H) for
pCaMKIIα expression in PSD extracts prepared from Wt cerebral cortical
neurons incubated 5 min with 5 nM of tPA, alone or in the presence of either
10 µM of MK-801 or 50 µM of BAPTA-AM. n = 4; lines denote SD.
(I,J) Experimental design and representative Western blot analysis (I) and
quantification of the mean intensity of the band (J) for pCaMKIIα expression in
PSD extracts prepared from Wt cerebral cortical neurons incubated with 1 µM
of tetrodotoxin (TTX) followed by 5 min of treatment with 5 nM of tPA. n = 4;
lines denote SD.
cortex of mice overexpressing neuronal tPA (T4 mice, with
a 20-fold increase in the release of neuronal tPA following
membrane depolarization) and their Wt littermate controls
following 1 min of either BCCAO or sham-operation. Our
data indicate that BCCAO increases the thickness of the
PSD from 27.87 ± 2.40 nm to 52.58 ± 2.55 nm in Wt
mice (p < 0.0001; n = 200), and from 28.38 ± 1.66 nm
to 74.29 ± 3.55 nm in T4 animals (p < 0.0001; n = 200;
Figures 3A,B). Furthermore, our immunohistochemical studies
revealed that BCCAO induces a marked increase in pCaMKIIα
expression in the II, IV and V cortical layers of Wt animals
(Figure 3C, panels b and f) and that this effect is significantly
enhanced by the overexpression of neuronal tPA (Figure 3C,
panels d and i). To determine whether the release of neuronal
tPA induces the phosphorylation and translocation of CaMKIIα
to the PSD in vivo, we studied the expression of pCaMKIIα
in PSD extracts prepared from the forebrain of Wt and
T4 mice following 1 min of either sham operation or BCCAO.
Our results show that the release of neuronal tPA induced
by BCCAO induces the phosphorylation and recruitment
of pCaMKIIα to the PSD in vivo and that this effect is
significantly enhanced by neuronal overexpression of tPA
(Figures 3D,E). As stated above for our in vitro experiments,
the use of equal concentrations of PSD extracts per experimental
condition ensures that this is not an epiphenomenon caused
by the observed increase in the thickness of the PSD, but
instead that it is due to a direct effect of neuronal tPA
on CaMKIIα phosphorylation and its subsequent recruitment
to the PSD.
TPA has a Bidirectional Effect on CaMKIIα
Phosphorylation
Our in vitro and in vivo data indicate that the release of
neuronal tPA promotes the phosphorylation and subsequent
recruitment of pCaMKIIα to the PSD of cerebral cortical neurons
that have low baseline levels of pCaMKIIα. To investigate
the effect of tPA on the phosphorylation and recruitment of
pCaMKIIα to the PSD of neurons with previously existing
high baseline levels of pCaMKIIα, we studied the effect of
tPA on the expression of pCaMKIIα in PSD extracts from
Wt cerebral cortical neurons in which the baseline levels of
pCaMKIIα were previously increased by incubation with a
combination of 200 µM of glycine and 20 µM of bicuculline,
and either low (2 µM) or high (10 µM) concentrations of
glutamate. We found that glutamate induces a dose-dependent
increase in the expression of pCaMKIIα in the PSD of cerebral
cortical neurons. However, while tPA potentiates the effect
of 2 µM of glutamate, it attenuates the effect of 10 µM
of glutamate on the phosphorylation and recruitment of
pCaMKIIα to the PSD (Figures 4A,B), by a mechanism that
does not require the conversion of plasminogen into plasmin
(Figures 4C,D).
Because the extracellular concentrations of Ca2+ increase
during neuronal activity, and since our data indicate that
tPA-induced CaMKIIα phosphorylation and accumulation in
the PSD requires the influx of Ca2+ via NMDA receptors
(Figures 2G,H), we decided to study whether variations in
the extracellular concentrations of Ca2+ have an effect on the
direction of the effect of tPA on CaMKIIα phosphorylation. To
accomplish this goal we quantified the number of pCaMKIIα-
positive puncta in dendrites of 375 neurons incubated with
0–1.8 mM of Ca2+ in the presence of either 5 nM of
tPA or vehicle (control). We found that tPA fails to induce
CaMKIIα phosphorylation in absence of Ca2+. However,
while pCaMKIIα expression did not change in the presence
of either 1 µM or 10 µM of Ca2+ alone, it increased
in the presence of 5 nM of tPA in combination with
either one of these concentrations of Ca2+. In contrast,
pCaMKIIα expression increased following incubation with
100 µM or 1.8 mM of Ca++ alone. However, while tPA
did not change the effect of 100 µM of Ca2+on pCaMKIIα
expression, it significantly attenuated it in cells incubated
with 1.8 mM (Figures 4E,F). Importantly, regardless of the
Ca2+ concentrations in each experimental group we did not
observe a statistically significant difference between the different
tPA-treated groups, suggesting that tPA brings pCaMKIIα
expression from lower or higher baseline levels to a preset
homeostatic physiological level.
To confirm the in vivo relevance of these findings we
performed similar observations with PSD extracts prepared
from the forebrain of Wt and T4 mice exposed to 60 s
of (BCCAO # 1- first release of neuronal tPA) followed by
5 min of reperfusion and 60 s of either sham-operation
or a second (BCCAO # 2- second release of neuronal
tPA). We found that the effect of BCCAO on CaMKIIα
phosphorylation and its subsequent recruitment to the PSD
is significantly enhanced by neuronal overexpression of tPA.
However, while an additional episode of neuronal release of
tPA induced by a second BCCAO further increased the levels
of pCaMKIIα in the PSD of Wt mice, it had the opposite
effect on T4 animals in which the first episode of BCCAO
had already induced very high levels of pCaMKIIα in the
PSD (Figures 4G,H). Together, our data show that tPA has a
bidirectional effect on the phosphorylation and recruitment of
CaMKIIα to the PSD that depends on the baseline levels of
pCaMKIIα.
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FIGURE 3 | In vivo effect of the release of neuronal tPA on CaMKIIα phosphorylation and accumulation in the PSD. (A) Representative electron
microscopy micrographs of the PSD of neurons from the frontal cortex of Wt (a,c) and T4 (b,d) mice following 1 min of either sham operation (a,b) or bilateral
common carotid artery occlusion (BCCAO; c,d). Magnification: 30,000×. (B) Mean thickness of 200 PSDs per experimental group from neurons from the frontal
cortex of Wt and T4 mice 60 s after either sham operation (white bars) or BCCAO (black bars). Lines denote SEM. (C) Representative micrographs (a–f,h,i) from the
frontal cortex of Wt and T4 mice stained with antibodies against pCaMKIIα (red in a,c,e,h white in d,f,i) 60 s after either sham operation or BCCAO. Panels (g,j)
correspond to heat maps (HT) from panels (f,i) Magnification: 40×. (D,E) Representative Western blot analysis (D) and mean intensity of the band (E) for pCaMKIIα
expression in extracts from the forebrain of Wt and T4 mice 60 s after either sham operation or BCCAO. Lines in (E) depict SD; n = 4.
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FIGURE 4 | TPA has a bidirectional effect on pCaMKIIα expression in the post-synaptic density. (A,B) Experimental design and representative Western blot
analysis (A) and quantification of the mean intensity of the band (B) for pCaMKIIα expression in extracts from the PSD from Wt cerebral cortical neurons incubated
with 200 µM of glycine, 20 µM of bicuculline and either 2 µM or 10 µM of glutamate, in the presence of 5 nM of tPA or a comparable volume of vehicle (control).
Lines denote SD; n = 4. (C,D) Experimental design and representative Western blot analysis (C) and quantification of the mean intensity of the band (D) for pCaMKIIα
(Continued)
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FIGURE 4 | Continued
expression in extracts from Wt cerebral cortical neurons incubated with vehicle
(control), or a combination of 10 µM of glutamate, glycine and bicuculline
either alone or in the presence of 5 nM of itPA. Lines denote SD; n = 4.
(E) Representative micrographs of pCaMKIIα expression in dendrites from Wt
cerebral cortical neurons following 90 s of treatment with either 5 nM of tPA or
vehicle (control) in the presence of 0–1.8 mM of calcium. Magnification: 100×.
(F) Mean number of pCaMKIIα-positive puncta in dendrites from Wt neurons
incubated with 5 nM of tPA or vehicle (control) in the presence of 0–1.8 mM of
calcium. Bars denote SEM. n = 350–375 dendrites per experimental
condition. (G,H) Experimental design and representative Western blot analysis
(E) and quantification of the mean intensity of the band (F) for pCaMKIIα
expression in PSD extracts prepared from the forebrain of Wt and T4 mice
following 60 s of (BCCAO #1) followed by 5 min of reperfusion (Rep.) and 60 s
of either a second (BCCAO #2) or sham operation. Lines denote SD; n = 4.
TPA Regulates the Activation of Protein
Phosphatase-1 in the Post-Synaptic
Density
Dephosphorylation by PP1 regulates pCaMKIIα activity in
the PSD (Bradshaw et al., 2003). Thus, we postulated that
the effects of tPA on CaMKIIα phosphorylation are mediated
by changes in the phosphorylation status of PP1. Because
phosphorylation or dephosphorylation of (I-1) at T35 (pT35I-1)
causes PP1 inactivation or activation, respectively, we decided
to study the expression of pT35I-1 in PSD extracts prepared
from Wt cerebral cortical neurons incubated with vehicle
(control), or with a combination of glutamate, bicuculline and
glycine, either alone or in combination with 5 nM of tPA,
or with tPA alone. Our data show that in cerebral cortical
neurons tPA does not have an effect I-1 phosphorylation at T35
(Figure 5A).
Recent studies have found that Cdk-5-induced
phosphorylation of PP1 at T320 (pPP1) is a calcineurin-
independent mechanism for PP1 inactivation that plays a
central role in the development of synaptic plasticity (Hou
et al., 2013). Thus, to investigate whether PP1 inactivation
by its phosphorylation at T320 mediates tPA-induced
CaMKIIα phosphorylation and recruitment to the PSD in
neurons with low baseline levels of pCaMKIIα, we studied the
expression of pPP1 (T320) in PSD extracts prepared from Wt
cerebral cortical neurons treated with 5 nM of tPA or vehicle
(control) in the presence or absence of the Cdk5 inhibitor
Rosc. We found that tPA induces PP1 phosphorylation at
T320 and that this effect is abrogated by Cdk5 inhibition
(Figures 5B,C). To further determine whether Cdk5-induced
PP1 phosphorylation at T320 mediates the effect of tPA on
CaMKIIα phosphorylation, we studied the expression of
pCaMKIIα in extracts prepared from the PSD of Wt cerebral
cortical neurons treated with tPA in the presence or absence of
Rosc. Together, our data indicate that Cdk5 activation mediates
the effect of tPA on PP1 inactivation by phosphorylation at T320,
and CaMKIIα phosphorylation and its subsequent recruitment
to the PSD (Figures 5D,E).
Then we investigated if PP1 activation by its
dephosphorylation at T320 mediates tPA-induced pCaMKIIα
dephosphorylation and its ensuing removal from the PSD
in neurons with previously existing high baseline levels
of pCaMKIIα, and whether Cdk-5 mediates this effect.
Because Cdk-5 inactivation is caused by ubiquitin-mediated
degradation of its activator p35 (Patrick et al., 1998), we
studied the expression of PP1 phosphorylated at T320 in cells
incubated with glycine, bicucculine and 10 µM of glutamate
(to increase baseline pCaMKIIα expression) and tPA, in the
presence or absence of the proteasomal inhibitor MG132. We
found that tPA induces PP1 dephosphorylation at T320 in
neurons with high baseline levels of phosphorylated PP1,
and that this effect is abrogated by proteasomal inhibition
(Figures 5F,G).
Our data show that the bidirectional effect of tPA on
CaMKIIα phosphorylation and recruitment to the PSD is
mediated by Cdk5 activation or inactivation. Then we postulated
that this effect is mediated by a bidirectional effect of tPA
on the expression of the Cdk5 activator p35. To test this
hypothesis, we studied the expression of p35 in plasma
membrane extracts from synaptoneurosomes prepared from
Wt cerebral cortical neurons either left untreated (to maintain
low levels of baseline neuronal activity) or incubated with a
combination of glycine, bicucculine and glutamate (to increase
baseline levels of neuronal activity), followed by treatment
with 5 nM of tPA. Our data indicate that tPA increases the
expression of p35 in previously inactive synapses, while it
decreases p35 expression in synapses that are already active
(Figures 5H,I).
TPA Induces pCaMKIIα-Dependent
Recruitment of GluR1-Containing AMPA
Receptors to the PSD
The conversion of ‘‘silent’’ into active synapses requires
pCaMKIIα-induced phosphorylation of GluR1 receptors at S831
(pGluR1) and their subsequent recruitment to the PSD (Lee et al.,
1998; Liao et al., 2001). Based on these observations we decided
to study the expression of pGluR1 in dendrites fromWt cerebral
cortical neurons treated with either 5 nM of tPA or a comparable
volume of vehicle control. We found that the number of pGluR1-
positive puncta/5 µm increases from 2.44 ± 0.43 in vehicle
(control)-treated cells to 11.92 ± 1.91 in neurons incubated
in the presence of tPA (p < 0.0001; Figures 6A,B). To study
the effect of tPA on pGluR1 expression in neurons with
already increased baseline levels of pGluR1 we performed similar
observations in cells incubated with glycine, bicucculine and
10 µM of glutamate (to increase the baseline expression of
pGluR1) either alone or in the presence of 5 nMof tPA.We found
that the number of pGluR1-positive puncta/5 µm decreases
from 19.32 ± 1.97 in neurons treated with glutamate alone
to 9 ± 1.59 in cells treated with glutamate in the presence of
tPA (p = 0.0002; Figures 6C,D). To ensure that the effect of
tPA on pGluR1 occurs in the PSD, we studied the expression
of pGluR1 and total GluR1 in PSD extracts prepared from
Wt cerebral cortical neurons incubated with or without a
combination of glycine, bicuculline and glutamate, alone or in
the presence of either 5 nM of tPA or a comparable volume
of vehicle (control). Our results show that in neurons with
low baseline levels of pGluR1 and total GluR1, tPA induces
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FIGURE 5 | Cyclin-dependent kinase 5 (Cdk5) mediates the effect of tPA on CaMKIIα phosphorylation and its subsequent accumulation in the
PSD. (A) Experimental design and representative Western blot analysis of the expression of inhibitor 1 phosphorylated at T35 in PSD extracts prepared from Wt
cerebral cortical neurons incubated with vehicle (control), or a combination of glutamate, glycine and bicuculline either alone, or in the presence of 5 nM of tPA,
or with tPA alone. (B,C) Experimental design and representative Western blot analysis (A) and quantification of the mean intensity of the band (B) for the
expression of protein phosphatase-1 (PP1) phosphorylated at T320 in PSD extracts from Wt cerebral cortical neurons incubated with 5 nM of tPA alone or in
the presence of 50 µM of the Cdk5 inhibitor roscovitine (Rosc); n = 4. Lines denote SD. (D,E) Experimental design and representative Western blot analysis (C)
and quantification of the mean intensity of the band (D) for the expression of pCaMKIIα in PSD extracts prepared from Wt cerebral cortical neurons treated with
tPA in the presence or absence of the Cdk5 inhibitor Rosc; n = 4. Lines denote SD. (F,G) Experimental design and representative Western blot analysis (E) and
quantification of the mean intensity of the band (F) for the expression PP1 phosphorylated at T320 in PSD extracts from Wt cerebral cortical neurons incubated
with 5 nM of tPA alone or in the presence of 10 µM of the proteasomal inhibitor MG132; n = 4. Lines denote SD. (H,I) Experimental design and representative
Western blot analysis (G), and quantification of the mean intensity of the band (H) for the expression of the Cdk5 activator p35 in PSD extracts prepared from
Wt cerebral cortical neurons either left untreated or incubated with a combination of glutamate, bicuculline and glycine alone or in the presence of 5 nM of tPA,
or incubated with tPA alone; n = 4. Lines denote SD.
their recruitment and phosphorylation to the PSD. In contrast,
when baseline the levels of total and pGluR1 levels are already
increased, tPA induces its dephosphorylation and mobilization
to extrasynaptic sites (Figures 6E,F). Finally, to determine
whether the observed effect of tPA on the phosphorylation
and mobilization to the PSD of AMPA receptors-containing
GluR1 subunits is mediated by pCaMKIIα, we studied the
expression of pGluR1 in PSD extracts from Wt cerebral cortical
neurons incubated either with tPA or vehicle (control), alone
or in the presence of the cell-permeable CaMKIIα inhibitor
KN-62. We found that pCaMKIIα mediates the effect of tPA
on GluR1 phosphorylation and its recruitment to the PSD
(Figures 6G,H).
DISCUSSION
A substantial body of experimental evidence indicates that tPA
modulates the efficiency of glutamatergic neurotransmission
in the CNS (Samson and Medcalf, 2006). Accordingly, tPA
is stored in non-glutamatergic dense core secretory granules
in the presynaptic terminal of cerebral cortical neurons and
its rapid release at extrasynaptic sites following membrane
depolarization modulates the exocytosis of glutamate-containing
SVs by a sequence of events that include translocation of SVs
from the reserve pool to the synaptic release site via Ca2+-
mediated synapsin I phosphorylation and recruitment of βII-
spectrin to the active zone (Wu et al., 2015). Importantly,
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FIGURE 6 | Effect of tPA on the phosphorylation and recruitment of GluR1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors to the PSD. (A) Representative micrographs of immunocytochemistry studies with antibodies against GluR1 phosphorylated at S831 (green and white),
PSD-95 (red) and phalloydin (blue) in dendrites from Wt neurons treated during 90 s with either vehicle (control) or 5 nM of tPA. Magnification: 100×. (B) Mean
number of pGluR1-positive puncta in dendrites from 75 neurons treated 90 s with vehicle (control) or 5 nM of tPA. Lines denote SEM. (C) Representative
micrographs of immunocytochemical staining for GluR1 phosphorylated at S831 (green and white), PSD-95 (red) and phalloydin (blue) in dendrites from 50 Wt
neurons treated during 90 s with a combination of 200 µM of glycine, 20 µM of bicuculline and 10 µM of glutamate (Glut), in the presence of 5 nM of tPA or a
comparable volume of vehicle (control). Magnification: 100×. (D) Mean number of pGluR1-positive puncta in the distal dendrites from 50 neurons treated 90 s with a
combination of 200 µM of glycine, 20 µM of bicuculine and 10 µM of glutamate (Glut), alone or in the presence of 5 nM of tPA. Lines denote SD.
(E,F) Representative Western blot analysis for pGluR1 and total GluR1 expression (E) and mean intensity of the band (F) in PSD extracts prepared from Wt cerebral
(Continued)
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FIGURE 6 | Continued
cortical neurons treated during 90 s with vehicle (control) or 5 nM of tPA, either
alone or in the presence of 200 µM of glycine, 20 µM of bicuculine and 10 µM
of glutamate (Glut). Lines in (F) denote SD. n = 4. (G,H) Representative
Western blot analysis for pGluR1 and total GluR1 expression (G) and mean
intensity of the band (H) in PSD extracts prepared from Wt cerebral cortical
neurons treated with vehicle (control) or 5 nM of tPA, either alone or in the
presence of 10 µM of the cell-permeable CaMKIIα inhibitor KN-62. Lines in
(H) denote SD. n = 4.
the effect of tPA on SVs exocytosis does not lead to
their depletion from the presynaptic terminal because tPA
also promotes their endocytic retrieval from the presynaptic
membrane via dynamin-I dephosphorylation (Yepes et al.,
2016).
The release of tPA at extrasynaptic sites and its
aforementioned effect on the synaptic vesicle cycle suggest
that in the CNS tPA plays a neuromodulatory role on
glutamatergic neurotransmission. In agreement with these
observations, the work presented here indicates that tPA
modulates the response of the postsynaptic terminal to the
presynaptic release of gutamate via its ability to regulate the
pCaMKIIα/PP1 switch in the PSD. Furthermore, our data
show that this role of tPA is independent of its ability to
induce the presynaptic release of glutamate (Wu et al., 2015)
and instead is mediated by postsynaptic NMDA receptors.
This effect may be pivotal for the homeostatic preservation of
synaptic function and circuit stability during conditions of either
synaptic depression or in those that such as cerebral ischemia
and seizures are characterized by the excitotoxic release of
glutamate.
The PSD is a disk-like structure apposed to the postsynaptic
membrane of the dendritic spine and assembled by specialized
protein complexes that determine the postsynaptic response to
the presynaptic release of neurotransmitters (Okabe, 2007). The
PSD is highly dynamic and its thickness changes in response
to variations in synaptic activity. For example, an increase
in the concentration of glutamate in the synaptic cleft, either
pharmacologically added (Dosemeci et al., 2001) or provoked
by the induction of cerebral ischemia (Aronowski and Grotta,
1996), causes a rapid and transient increase in the thickness
of the PSD. The data presented here show that the release
of neuronal tPA or incubation with tPA also increases the
thickness of the PSD, suggesting a functional link between
glutamatergic neurotransmission and tPA release. Together
with our earlier studies indicating that tPA also increases
the size of the active zone of the presynaptic terminal (Wu
et al., 2015), these observations suggest that tPA induces the
morphological and functional changes in the presynaptic and
postsynaptic terminals required for successful glutamatergic
neurotransmission.
CaMKII is a holoenzyme that accounts for a large proportion
of the total protein content of the PSD. Indeed, there are
approximately 80 CaMKII complexes per 0.1 µm2 of PSD,
and in some PSDs there is more CaMKII than the scaffold
protein PSD-95 (Chen et al., 2008). In agreement with these
observations, the enlargement of the PSD in neurons exposed to
either high concentrations of glutamate or to an ischemic injury
has been associated with phosphorylation and accumulation
of pCaMKIIα in the postsynaptic terminal (Aronowski and
Grotta, 1996; Martone et al., 1999; Dosemeci et al., 2001).
Our data indicate that the release of neuronal tPA mediates
and modulates the effect of glutamate on the phosphorylation
and recruitment of pCaMKIIα to the PSD, and that this
modulatory role is mediated by Ca2+ influx via NMDA
receptors. Moreover, it is important to note that our studies
with PSD extracts ensure that this effect occurs in the PSD
instead of other cellular compartments where CaMKII also plays
important roles. Furthermore, our data are in agreement with
work by others (Nicole et al., 2001) indicating an interaction
between tPA and NMDA receptors. However, in contrast with
these reports, in our model this interaction does not require
FIGURE 7 | Schematic representation of the proposed role for tPA as a
homeostatic regulator of synaptic function. (A) PSD of a silent (blue) and
an active (red) synapse. Note that the levels of PP1 activity are high in the
silent synapse and low in the active synapse owning to the absence or
presence, respectively, of Cdk5-induced PP1 phosphorylation at T320, which
leads to correspondingly low and high levels of pCaMKIIα. The figure also
depicts the presence of N-methyl-D-aspartate (NMDA; blue triangles) but not
GluR1-containing AMPA receptors (green cylinders) in the silent synapse.
(B) Synaptic depolarization induces the release of tPA (orange circles) that
then interacts with the PSD of both synapses. (C) tPA induces the recruitment
of p35 to the PSD of the silent synapse and its proteasomal degradation in the
active synapse. This leads in the silent synapse to Cdk5-induced inactivation
of PP1 by phosphorylation at T320, with a resultant increase in pCaMKIIα in
the PSD, and pCaMKIIα-induced phosphorylation and recruitment of
GluR1 subunits to the PSD.
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tPA’s proteolytic properties, which is in line with observations
by several other groups (Samson et al., 2008) reporting a
non-proteolytic interaction between tPA and NMDA receptors
that is mediated by the low-density lipoprotein receptor-related
protein-1 (LRP-1). The results presented here indicate that
the effect of tPA on the phosphorylation and recruitment
of CaMKIIα to the PSD require synaptic NMDA receptors.
Unfortunately, the experimental design of our work does not
allow us to determine whether NMDA receptors also mediate the
opposite effect (i.e., decreasing pCaMKIIα in the PSD of already
active synapses).
Several studies have suggested that the phosphorylation
and accumulation of pCaMKIIα in the PSD is neurotoxic in
pathological situations characterized by the excitotoxic release
of glutamate (Coultrap et al., 2011; Skelding et al., 2012). Based
on these observations it is conceivable to postulate that tPA
may have a neurotoxic effect mediated by its ability to promote
the phosphorylation and accumulation of pCaMKIIα in the
PSD. However, our data indicates that this is not the case.
Instead, we found that when pCaMKIIα is already increased in
the PSD tPA induces its dephosphorylation via PP1 activation.
These results agree with previous studies demonstrating that
tPA has a homeostatic effect in the synapse under physiological
and pathological conditions (Wu et al., 2012, 2013b; Yepes,
2015). Importantly, our data indicate that as shown by others
(Hou et al., 2013) the baseline levels of PP1 phosphorylated
at T35 are almost undetectable, and that tPA does not have
an effect on I-1 phosphorylation at T35. Instead, our results
indicate that tPA has a direct effect on PP1 phosphorylation
at T320.
AMPARs are assembled by four subunits with distinct
electrophysiological properties (GluR1, 2, 3 and 4).
Accordingly, AMPARs containing GluR2 subunits show
lower permeability for Ca2+ while GluR1 subunits confer
high Ca2+ permeability. Several electrophysiological studies
indicate that a large fraction of glutamatergic synapses contain
NMDA but not AMPA receptors. These are considered
as ‘‘silent synapses’’ that however can be activated by the
recruitment of AMPA receptors to the PSD (Liao et al.,
2001). More specifically, during synaptic inactivity GluR1-
containing AMPARs are restricted from the synapses, but
they are recruited to the PSD by activity-induced synaptic
enhancement (Hayashi et al., 2000). pCaMKIIα plays a pivotal
role in the conversion from silent to active synapses. Indeed,
pCaMKIIα-induced phosphorylation of GluR1 subunits at S831
(pGluR1) is necessary for their recruitment to the PSD and
the resultant enhancement in AMPAR conductance required
for the activation of the postsynaptic terminal (Kristensen
et al., 2011). Importantly, depending on the baseline level of
neuronal function, activation of NMDA receptors is capable
to induce both, phosphorylation and dephosphorylation of
GluR1 subunits, with the subsequent activation or inhibition of
synaptic activity (Lisman and Zhabotinsky, 2001). This event,
known as bidirectional synaptic plasticity (Lee et al., 2000), plays
a pivotal role not only in learning but also in the development
of homeostatic plasticity needed to maintain neuronal activity
within a physiological range (Turrigiano, 2008). The data
presented here show that tPA mediates the development of
this process and that its direction depends on the extracellular
concentrations of Ca2+ and the baseline level of neuronal
activity.
It has been proposed that a highly sensitive
CaMKIIα/PP-1 switch regulates the response of the postsynaptic
terminal to changes in the extracellular concentrations of Ca2+
(Bradshaw et al., 2003). However, the biochemical mechanisms
that determine the direction of this switch are still unknown.
We found that an as yet uncharacterized interaction between
tPA and Cdk5 regulates the CaMKIIα/PP1 balance in the PSD
according to the baseline levels of pCaMKIIα phosphorylation
and the extracellular concentrations of Ca2+, and that this effect
leads to mobilization of GluR1-containing AMPA receptors in
and out of the PSD with the subsequent formation of active or
silent synapses, respectively.
In summary, based on the data presented here we postulate
a model whereby its ability to have a bidirectional effect on the
CaMKIIα/PP-1 switch and the subsequent phosphorylation and
recruitment of GluR1-containing AMPA receptors to the PSD,
tPA is a homeostatic regulator of the postsynaptic response to
the presynaptic release of glutamate (Figure 7). We postulate
that this homeostatic mechanism is pivotal for the stabilization of
individual synapses that are either depressed by lack of synaptic
input or overstimulated by an excitotoxic injury.
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